BIOMAT Database Logo BIOMAT Database Logo

Isolated testicular relapse after bone marrow transplantation for acute lymphoblastic leukaemia. 1983

R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Bone marrow transplantation for childhood acute lymphoblastic leukaemia after marrow relapse.
April 1990, The Medical journal of Australia,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation.
November 1999, Bone marrow transplantation,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Prophylactic orchiectomy after bone marrow transplantation for boys with acute lymphoblastic leukaemia and previous testicular relapse.
January 1991, Bone marrow transplantation,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not?
January 1989, Lancet (London, England),
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Relapse after bone marrow transplantation for acute leukaemia.
July 1985, Lancet (London, England),
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
January 1993, Acta haematologica,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation.
September 1986, British journal of haematology,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Isolated breast relapse after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
January 1992, Medical and pediatric oncology,
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry.
March 1989, Lancet (London, England),
R F Ashford, and A M Cassoni, and S Bowcock, and R H Phillips, and J Kendra, and R Joshi, and J Barratt
Bone-marrow transplantation for acute lymphoblastic leukaemia.
September 1983, Lancet (London, England),
Copied contents to your clipboard!